Pentoxifylline adjunct to risperidone for negative symptoms of stable schizophrenia: a randomized, double-blind, placebo-controlled trial.

MLA

Shamabadi, Ahmad, et al. “Pentoxifylline Adjunct to Risperidone for Negative Symptoms of Stable Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Trial.” The International Journal of Neuropsychopharmacology, vol. 28, no. 1, Dec. 2024. EBSCOhost, https://doi.org/10.1093/ijnp/pyae051.

APA

Shamabadi, A., Rafiei-Tabatabaei, E.-S., Kazemzadeh, K., Farahmand, K., Fallahpour, B., Khodaei Ardakani, M.-R., & Akhondzadeh, S. (2024). Pentoxifylline adjunct to risperidone for negative symptoms of stable schizophrenia: a randomized, double-blind, placebo-controlled trial. The International Journal of Neuropsychopharmacology, 28(1). https://doi.org/10.1093/ijnp/pyae051

Chicago

Shamabadi, Ahmad, Elham-Sadat Rafiei-Tabatabaei, Kimia Kazemzadeh, Kimia Farahmand, Bita Fallahpour, Mohammad-Reza Khodaei Ardakani, and Shahin Akhondzadeh. 2024. “Pentoxifylline Adjunct to Risperidone for Negative Symptoms of Stable Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Trial.” The International Journal of Neuropsychopharmacology 28 (1). doi:10.1093/ijnp/pyae051.